Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

27.2K
Overview
27.2K
Autoimmune Disorders01:29

Autoimmune Disorders

374
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
374
Hypersensitivities01:30

Hypersensitivities

479
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
479
Cross-reactivity00:42

Cross-reactivity

30.9K
Overview
30.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The CHRNA5 rs16969968 variant is associated with MMP-9 expression and inflammatory signaling in COPD in a West Bengal population, India.

Frontiers in pharmacology·2026
Same author

Investigating the role of single-nucleotide polymorphisms of PTGS2 and IL17 gene with allergic asthma susceptibility in the Indian population.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Indian society of electrocardiology position statement on improving CPR awareness in the Indian public.

Indian heart journal·2026
Same author

Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in contemporary cardiometabolic care.

Diabetology international·2026
Same author

Real-world evidence of urinary tract infections and genital tract infections with sodium-glucose cotransporter-2 inhibitors (SGLT2i) alone or in combination with dipeptidyl peptidase-4 inhibitors (DPP4i) in individuals with type-2 diabetes mellitus in India.

BMC endocrine disorders·2026
Same author

Reappraising gestational hyperglycaemia: a manifestation of lifelong glycaemia or a correlation of glycaemic indices across life stages.

Diabetologia·2026

Related Experiment Video

Updated: May 23, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.3K

Allergen Immunotherapy in Autoimmune Terrain: A Case Study.

Shambo S Samajdar1,2,3, Saibal Moitra4, Shatavisa Mukherjee5

  • 1Diabetes and Allergy-Asthma Therapeutics Specialty Clinic, Kolkata, India.

Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India
|March 11, 2025
PubMed
Summary

Allergen immunotherapy (AIT) can cause autoimmune hypothyroidism, but continuing treatment with thyroid hormone replacement is often beneficial. This case highlights personalized medicine for patients with coexisting allergic and autoimmune conditions.

Keywords:
Allergen immunotherapyAllergic rhinitisAutoimmune hypothyroidismClinical pharmacologyRisk-benefit analysis

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.0K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.2K

Related Experiment Videos

Last Updated: May 23, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.3K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.0K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.2K

Area of Science:

  • Immunology
  • Endocrinology
  • Clinical Pharmacology

Background:

  • Allergen immunotherapy (AIT) induces immune tolerance for allergic diseases but its use in autoimmune conditions is debated.
  • Concerns exist regarding AIT potentially triggering or worsening autoimmune diseases.
  • Managing patients with both allergic and autoimmune conditions requires careful consideration.

Purpose of the Study:

  • To examine a case of autoimmune hypothyroidism developing during AIT.
  • To evaluate management decisions for a patient with coexisting allergic rhinitis and newly diagnosed hypothyroidism.
  • To assess the risk-benefit profile of continuing AIT in this context.

Main Methods:

  • A case report of a 26-year-old female patient undergoing AIT for allergic rhinitis.
  • Monitoring of thyroid function tests (TSH, anti-TPO antibodies) during AIT.
  • Causality assessment for AIT-induced hypothyroidism and risk-benefit analysis for treatment continuation.

Main Results:

  • The patient developed hypothyroidism with elevated TSH and positive anti-TPO antibodies three months into AIT.
  • A "possible" link was identified between AIT and the onset of hypothyroidism.
  • Continuation of AIT alongside L-thyroxine therapy led to normalized TSH and improved allergic rhinitis symptoms.

Conclusions:

  • AIT can be continued in patients who develop hypothyroidism, provided it is managed with hormone replacement therapy.
  • Personalized risk-benefit analysis is crucial for managing patients with coexisting allergic and autoimmune diseases.
  • Understanding immune modulation (e.g., Th17/Treg balance, neutrophils) is key for optimizing AIT in complex cases.